PATENT CLAIM ANALYSIS

Application Number: 15996166
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2019-01
Patent Classification: ["514", "267000"]

Abstract:
The present invention relates to compounds and methods for the treatment of cancer. In particular, the invention provides potent inhibitors of Aurora A kinase, pharmaceutical compositions comprising the compounds, and methods of using the compounds for the treatment of cancer.

Claim (Index 27):
The method of  claim 26 , wherein the cancer is selected from the group consisting of colorectal cancer, ovarian cancer, breast cancer, gastric cancer, prostate cancer, and pancreatic cancer.

Metadata:
- Claim Count in Document: 50.0
- Percentile: 94.0
- Lexical Diversity: 1.66667
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['12231661', '11242413', '12472583', '14810225', '11127855']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8150157163354087
- 35 USC 102 Novelty (BERT): 0.5193501618960701
- Combined Prediction Score: 0.7854491608914749
- Mean Citation Score: 273.41086
- Max Citation Score: 279.73486
- Similarity Product: 154.42315941851382

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test